Condition: Non-Hodgkin Lymphoma · Lymphoma Non-Hodgkin · B-cell Lymphoma · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
The goal of this observational cohort study is to learn how toxin and occupational exposures, germline genetic variation, and immune dysregulation relate to B-cell non-Hodgkin lymphoma among active-duty service members and other Military Health System beneficiaries. The main questions are whether specific exposures and germline variants are associated with B-cell NHL subtype, immune dysfunction, and clinical outcomes. Participants will complete exposure and medical-history surveys, provide biospecimens for immune and genomic testing, and may be followed annually for up to 3 years.
This description comes directly from the study's public registry record.
Christin B. Destefano, MD, Lt Col, MC, USAF · (301) 295-3190 · christin.destefano@usuhs.edu
W. Grant Day, MD, LCDR, MC, USN · (757) 953-2194 · william.g.day26.mil@health.mil
Always discuss trial participation with your own doctor first.
| Uniformed Services University of the Health Sciences | Bethesda, Maryland, United States | Active Not Recruiting |
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | Recruiting |
| Naval Medical Center Portsmouth | Portsmouth, Virginia, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07652580